PAVmed shareholders approve stock issuance, charter amendment, and equity plan changes

PAVmed Inc. shareholders approved three key proposals at a special meeting, as detailed in a recent SEC filing. These approvals include the issuance of common stock related to a private placement and convertible note, an amendment to the company’s certificate of incorporation allowing for director removal with or without cause, and an increase in shares available under the 2014 Long-Term Incentive Equity Plan. The company’s stock has recently declined, and these actions follow a previously announced 1-for-30 reverse stock split to maintain Nasdaq listing compliance.